lobbying_activities: 468696

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
468696	3cbe13dc-d009-4990-9c67-fca099aa8ccd	YY	PARRY, ROMANI, DECONCINI & SYMMS	30792	NOVARTIS CORP	2006	year_end	CPT	H.R. 2791: To amend title 35, United States Code, with respect to patent fees, and for other purposes. Lobbied for reasonable patent fees and to protect intellectual property rights. H.R. 357, S. 167: To provide for the protection of intellectual property rights, and for other purposes. Lobbied to protect the Biopharmaceutical industry's intellectual property rights. H.R. 2795: To amend title 35, United States Code, relating to the procurement, enforcement, and validity of patents. Lobbied to protect the Biopharmaceutical industry's intellectual property rights. S. 167: a bill to provide for the protection of intellectual property rights, and for other purposes. Lobbied to protect the Biopharmaceutical industry's intellectual property rights. H.R. 2795: To amend title 35, United States Code, relating to the procurement, enforcement, and validity of patents. Lobbied to protect intellectual property rights.	Centers For Disease Control & Prevention (CDC),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),HOUSE OF REPRESENTATIVES,Natl Institutes of Health (NIH),SENATE	100000		0	0	2007-02-05T11:03:32-05:00